YOUR BUSINESS AUTHORITY
Springfield, MO
The Food and Drug Administration has given the green light to a new non-opioid painkiller from Vertex Pharmaceuticals.
Journavx, or suzetrigine, is said to be the first of its kind approved by regulators.
“With the approval of Journavax, a non-opioid, pain signal inhibitor and the first new class of pain medicine approved in more than 20 years, we have the opportunity to change the paradigm of acute pain management and establish a new standard of care,” Vertex CEO Reshma Kewalramani said.
Read more from Quartz.
Project work in Springfield corridor will continue into 2031.
Thanksgiving staple recalled at Costco
Warren Buffett donates $5.5B worth of Berkshire Hathaway shares
HBA of Greater Springfield executive officer to retire
Transportation officials discuss $471M Forward 44 initiative
Monday Morning Business Leads: Nov. 16, 2026
Former OMB Bank officer placed on probation
Letter to the Editor: No half-baked cake for our kids. No half-baked school grades, either.